Kapil Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 28-06-2024
- Paid Up Capital ₹ 1.50 M
as on 28-06-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -334.92%
(FY 2022)
- Ebitda -1079.19%
(FY 2022)
- Net Worth -1.24%
(FY 2022)
- Total Assets -1.24%
(FY 2022)
About Kapil Life Sciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Burgu Reddy and Naresh Vididhineni serve as directors at the Company.
- CIN/LLPIN
U01100TG2020PTC140673
- Company No.
140673
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2020
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kapil Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Burgu Reddy  | Director | 18-Jun-2020 | Current |
| Naresh Vididhineni | Director | 07-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Kapil Life Sciences.
Kapil Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 334.92% decrease in profit. The company's net worth dipped by a decrease of 1.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kapil Life Sciences?
Unlock access to Kapil Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bvm Energy And Residency Private LimitedActive 15 years 8 monthsNaresh Vididhineni is a mutual person
Kapil Agro Farm India Private LimitedActive 17 years 1 monthBurgu Reddy and Naresh Vididhineni are mutual person
- Kausalya Infra Projects Private LimitedActive 36 years 7 months
Naresh Vididhineni is a mutual person
- Dakshin Infrastructures Private LimitedActive 18 years 9 months
Naresh Vididhineni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kapil Life Sciences?
Kapil Life Sciences has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kapil Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kapil Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
